Moreover, multivariate analyses revealed that CASC2 expression was an independent prognostic indicator of HCC patients regarding OS and DFS (Table 1), suggesting CASC2 might be a promising biomarker of prognosis. Here, CASC2 is linked to hepatocellular carcinoma.